| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-60598 |
NSC 377071
|
26097-80-3 |
NSC 377071 (NSC-377071, NSC377071, Cambendazole) is a novel ATG4B antagonist that inhibits autophagy, with no effect on mTOR and PI3K activities. |
| PC-60597 |
NSC 185058
|
39122-38-8 |
NSC 185058 (NSC185058, NSC-185058, 2-Pyridinecarbothioamide) is a novel ATG4B antagonist that inhibits autophagy with IC50 of 50 uM, with no effect on mTOR and PI3K activities. |
| PC-42186 |
FMK-9a
|
1955550-51-2 |
FMK-9a (FMK9a) is a potent, selective, covalent peptidomimetic inhibitor of ATG4B (Autophagin-1) with IC50 of 80 nM in TR-FRET assay. |
| PC-72137 |
Atg4B inhibitor 21f
|
|
Atg4B inhibitor 21f is a potent competitive inhibitor for Atg4B with Ki of 3.1 uM. |
| PC-72136 |
UAMC-2526
|
2116590-65-7 |
UAMC-2526 (UAMC2526) is a low micromolar ATG4B and autophagy inhibitor. |
| PC-35632 |
S130
|
1160852-22-1 |
S130 (ATG4B inhibitor S130) is a potent, specific ATG4B inhibitor with IC50 of 3.24 uM, shows strong affinity (Kd=4 uM) and specifically suppresses the activity of ATG4B, but not other proteases. |
| PC-35540 |
LV-320
|
|
LV-320 (LV320) is a novel potent, cell-active, allosteric inhibitor of the autophagy-related cysteine protease ATG4B with IC50 of 24.5 uM in ATG4B cleavage assays. |
